The prostate stem cell is a target of vitamin D chemoprevention
The prostate stem cell is a target of vitamin D chemoprevention
批准号:
8105199
负责人:
Scott D Cramer
金额:
$30.28万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-07-06 至 2015-05-31
关键词:
AKT1 geneAdultAllelesAndrogen ReceptorAnimalsApoptosisBenignBicalutamideBiological AssayBromodeoxyuridineCarcinomaCell CycleCell Cycle ArrestCell Cycle ProgressionCellsChemopreventionCholecalciferolCleaved cellDataDietDiseaseEpithelial CellsExhibitsGene ExpressionGenetic ModelsGrowthHealthHistopathologyHumanIL1R1 geneImmunohistochemistryIn VitroInterleukin-1Interleukin-1 alphaIntraepithelial NeoplasiaMalignant neoplasm of prostateMediatingModelingMusNuclearOncogenesPathway interactionsPreventionProcessProliferation MarkerProstateProstate carcinomaProstaticProstatic Intraepithelial NeoplasiasProstatic NeoplasmsProtein IsoformsProto-Oncogene Proteins c-aktRNAReceptor SignalingRegulationRelative (related person)ReporterRoleSignal PathwaySignal TransductionStem cellsSupplementationTestingTissue RecombinationTissuesVitamin DVitamin D Response ElementVitamin D2Vitamin D3 Receptorcancer riskcaspase-3cell growthchromatin immunoprecipitationdeletion analysisextracellularfeedingin vivomouse modelnoveloncoprotein p21progenitorpromoterprostate cancer preventionpublic health relevancereceptorreceptor expressionresponsesenescencesmall hairpin RNAtumor progressiontumorigenesis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Circulating vitamin D levels are inversely associated with prostate cancer risk and supplementation with vitamin D for prostate cancer prevention has been proposed. We recently developed a mouse model of adult prostate progenitor/stem cells (PrP/SC). The adult tissue specific stem cell may be an important target for chemoprevention. We have interrogated the effects of the active metabolite of vitamin D, 1a,25-dihydroxyvitamin D3 [1,25(OH)2D3], on the PrP/SC. 1,25(OH)2D3 blocks proliferation, induces cell cycle arrest, and increases expression of cyclin-dependent kinase inhibitors p21 and p27. Our data suggest that 1,25(OH)2D3 promotes differentiation of the PrP/SC. Consistent with prodifferentiation we observe increased androgen receptor (AR) expression in 1,25(OH)2D3-treated PrP/SC. To identify novel targets of vitamin D receptor transcriptional activity and to assess global gene expression changes we probed gene expression arrays with RNA from 1,25(OH)2D3-treated PrP/SC. We identified a signaling pathway that is both necessary and sufficient for 1,25(OH)2D3 antiproliferative actions on the PrP/SC and is required for induction of AR. Preliminary data also demonstrate a moderate cell cycle block and a more profound induction of senescence, which is dependent on this pathway. This project will interrogate the role of this pathway in vitamin D signaling in the prostate stem cell in more detail. We will evaluate the mechanism of regulation by vitamin D and how this pathway intersects with AR signaling, we will determine the signaling pathway leading to senescence in response to vitamin D both in vitro and in vivo, and we will test the ability of vitamin D to block prostate tumor progression in a genetic model of prostate cancer that exhibits progression through prostatic intraepithelial neoplasia in a p27-dependent manner. Overall these studies will impact our understanding of the effects of vitamin D signaling on prostate stem cell growth arrest, differentiation and senescence and the functional roles of vitamin D in the prevention of prostate tumor progression.
PUBLIC HEALTH RELEVANCE: Prostate cancer is a significant health problem in the US which is a candidate disease for chemoprevention strategies. This project will dissect the underlying mechanisms of vitamin D-induced changes on the prostate stem cell, a viable target for chemoprevention strategies. This project will further our efforts to develop rationale chemoprevention strategies for prostate cancer.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
-
批准号:10657393
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2021
-
负责人:Scott D Cramer
-
依托单位:
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
-
批准号:10276486
-
项目类别:
-
资助金额:$39.19万
-
财政年份:2021
-
负责人:Scott D Cramer
-
依托单位:
Androgen Signaling in CaP with loss of MAP3K7 and CHD1
-
批准号:10439892
-
项目类别:
-
资助金额:$38.41万
-
财政年份:2021
-
负责人:Scott D Cramer
-
依托单位:
Training Program in Cancer Biology
-
批准号:10332080
-
项目类别:
-
资助金额:$25.18万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
Autophagy regulation of prostate tumor development
-
批准号:9096644
-
项目类别:
-
资助金额:$20.29万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
Training Program in Cancer Biology
-
批准号:9404559
-
项目类别:
-
资助金额:$0.54万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
Training Program in Cancer Biology
-
批准号:9312767
-
项目类别:
-
资助金额:$37.6万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
Training Program in Cancer Biology
-
批准号:10670055
-
项目类别:
-
资助金额:$39.44万
-
财政年份:2016
-
负责人:Scott D Cramer
-
依托单位:
CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer
-
批准号:9265055
-
项目类别:
-
资助金额:$34.19万
-
财政年份:2015
-
负责人:Scott D Cramer
-
依托单位:
CHD1 and TAK1 Synthetic Lethality in Prostate Cancer
-
批准号:8873686
-
项目类别:
-
资助金额:$16.9万
-
财政年份:2015
-
负责人:Scott D Cramer
-
依托单位:
CHD1 and MAP3K7 coordinate deletion in aggressive ERG translocation negative prostate cancer
-
批准号:9090060
-
项目类别:
-
资助金额:$38.87万
-
财政年份:2015
-
负责人:Scott D Cramer
-
依托单位:
CHD1 and TAK1 Synthetic Lethality in Prostate Cancer
-
批准号:9047256
-
项目类别:
-
资助金额:$20.29万
-
财政年份:2015
-
负责人:Scott D Cramer
-
依托单位:
Isolation of Tumor Initiating Cells (TICs) using Contactless Dielectrophoresis
-
批准号:8547799
-
项目类别:
-
资助金额:$18.73万
-
财政年份:2012
-
负责人:Scott D Cramer
-
依托单位:
Isolation of Tumor Initiating Cells (TICs) using Contactless Dielectrophoresis
-
批准号:8431874
-
项目类别:
-
资助金额:$18.03万
-
财政年份:2012
-
负责人:Scott D Cramer
-
依托单位:
The prostate stem cell is a target of vitamin D chemoprevention
-
批准号:8676711
-
项目类别:
-
资助金额:$29.37万
-
财政年份:2010
-
负责人:Scott D Cramer
-
依托单位:
The prostate stem cell is a target of vitamin D chemoprevention
-
批准号:8326107
-
项目类别:
-
资助金额:$30.28万
-
财政年份:2010
-
负责人:Scott D Cramer
-
依托单位:
The prostate stem cell is a target of vitamin D chemoprevention
-
批准号:8469833
-
项目类别:
-
资助金额:$28.46万
-
财政年份:2010
-
负责人:Scott D Cramer
-
依托单位:
Tak1, a novel prostate cancer tumor suppressor
-
批准号:8053797
-
项目类别:
-
资助金额:$9.31万
-
财政年份:2009
-
负责人:Scott D Cramer
-
依托单位:
Tak1, a novel prostate cancer tumor suppressor
-
批准号:7828004
-
项目类别:
-
资助金额:$30.71万
-
财政年份:2009
-
负责人:Scott D Cramer
-
依托单位:
Tak1, a novel prostate cancer tumor suppressor
-
批准号:8316493
-
项目类别:
-
资助金额:$21.24万
-
财政年份:2009
-
负责人:Scott D Cramer
-
依托单位:
海外基金